Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Nature Clinical Practice. Urology|February 14, 2006
Drug Insight: lycopene in the prevention and treatment of prostate cancerEmma S Guns, Simon P CowellEuropean Journal of Drug Metabolism and Pharmacokinetics|June 18, 2002
Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapyEmma S Guns, Tetyana Denyssevych, Ross Dixon, et al.The Prostate|November 15, 2007
Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT)Jennifer A Locke, Kishor M Wasan, Colleen C Nelson, et al.The Prostate|March 3, 2004
P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cellsMatthew N Fedoruk, Pepita Giménez-Bonafé, Emma S Guns, et al.Cancer Chemotherapy and Pharmacology|February 13, 2007
Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenograftsJonathan C Low, Kishor M Wasan, Ladan Fazli, et al.Nutrition and Cancer|July 21, 2007
Evaluation of the antiproliferative effects of Essiac on in vitro and in vivo models of prostate cancer compared to paclitaxelAndy Eberding, Candice Madera, Sherwin Xie, et al.Frontiers in Neuroendocrinology|September 17, 2014
Regulation of local steroidogenesis in the brain and in prostate cancer: lessons learned from interdisciplinary collaborationH Bobby Fokidis, Hans H Adomat, Geetanjali Kharmate, et al.Clinical Nutrition (Edinburgh, Scotland)|March 6, 2007
Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell linesNikita I Ivanov, Simon P Cowell, Paula Brown, et al.The Journal of Urology|April 8, 2006
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer modelsXiaowei Xie, Andy Eberding, Candice Madera, et al.Phytotherapy Research : PTR|October 13, 2005
Bioactive compounds from Rhodiola rosea (Crassulaceae)Dong Sheng Ming, Brian J Hillhouse, Emma S Guns, et al.Pageof 2